Reconstitution of B cell immunity following bone marrow transplantation
- PMID: 1628122
Reconstitution of B cell immunity following bone marrow transplantation
Abstract
Bone marrow transplant recipients are known to be immunodeficient in cellular and humoral immune responses for months to years. Mechanisms underlying the post-transplant immunodeficiency are mostly unknown and therefore it has been difficult to design therapeutic strategies to address this problem. Here, we review studies of post-transplant B cell (humoral) immunity including B cell blood counts, phenotype, function and origin, and the morphology of lymphoid organs. We postulate that the aetiology of post-transplant humoral immunodeficiency is multifactorial, involving: B cell immaturity due to recapitulation of their ontogenesis, and, in some patients, insufficient T cell help and/or exaggerated CD8+ T cell/NK cell suppression. Implications for clinical practice are outlined, e.g. hypersensitivity reactions and autoimmune diseases as part of the differential diagnosis of post-transplant disorders, questionable diagnostic benefit of serologic studies, and usefulness of prophylactic intravenous immunoglobulin.
Similar articles
-
B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency.Bone Marrow Transplant. 2002 Apr;29(7):625-8. doi: 10.1038/sj.bmt.1703410. Bone Marrow Transplant. 2002. PMID: 11979315
-
Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.Haematologica. 2005 Jan;90(1):86-93. Haematologica. 2005. PMID: 15642674 Clinical Trial.
-
Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients.Bone Marrow Transplant. 2001 Oct;28(8):775-81. doi: 10.1038/sj.bmt.1703239. Bone Marrow Transplant. 2001. PMID: 11781630
-
Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.Bone Marrow Transplant. 1997 Mar;19(5):491-5. doi: 10.1038/sj.bmt.1700677. Bone Marrow Transplant. 1997. PMID: 9052917 Review.
-
[B-cell content after bone marrow transplantation--molecular basis of the limited antibody diversity].Orv Hetil. 2001 Jan 28;142(4):163-7. Orv Hetil. 2001. PMID: 11232152 Review. Hungarian.
Cited by
-
White pulp reconstitution after human bone marrow transplantation.Am J Pathol. 1993 Oct;143(4):1111-20. Am J Pathol. 1993. PMID: 8214005 Free PMC article.
-
Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II-III trial (T-cell depletion trial).Bone Marrow Transplant. 2010 Mar;45(3):587-9. doi: 10.1038/bmt.2009.170. Epub 2009 Jul 20. Bone Marrow Transplant. 2010. PMID: 19617904 Free PMC article. Clinical Trial. No abstract available.
-
Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.Biol Blood Marrow Transplant. 2013 Nov;19(11):1581-9. doi: 10.1016/j.bbmt.2013.08.003. Epub 2013 Aug 11. Biol Blood Marrow Transplant. 2013. PMID: 23939199 Free PMC article.
-
Transmission of lupus anticoagulant by allogeneic stem cell transplantation.Rev Bras Hematol Hemoter. 2014 Jul-Aug;36(4):287-9. doi: 10.1016/j.bjhh.2014.05.008. Epub 2014 May 29. Rev Bras Hematol Hemoter. 2014. PMID: 25031168 Free PMC article.
-
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.Biol Blood Marrow Transplant. 2017 Jun;23(6):870-881. doi: 10.1016/j.bbmt.2016.10.001. Epub 2016 Oct 14. Biol Blood Marrow Transplant. 2017. PMID: 27751936 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials